⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL22635867 | 0.93 | BRD4 (0.41) | — | |
| SCHEMBL7029657 | 0.91 | BRD4 (0.39) | — | |
| SCHEMBL31161185 | 0.84 | — | — | |
| SCHEMBL20909425 | 0.78 | BRD4 (0.41) | — | |
| SCHEMBL9634467 | 0.78 | BRD4 (0.41) | — | |
| SCHEMBL6046209 | 0.75 | — | — | |
| SCHEMBL9434905 | 0.75 | BRD4 (0.43) | — | |
| SCHEMBL11033699 | 0.73 | PIK3CD (0.42) | — | |
| SCHEMBL11240360 | 0.72 | BRD4 (0.36) | — | |
| SCHEMBL4511131 | 0.72 | ALDH1A1 (0.43) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-118873688-A | Chrysanthemum carbon quantum dot drug-loaded nanoparticle, chrysanthemum pollen drug depot and application thereof in soluble microneedle drug delivery system | 上海中医药大学 | 2024-11-01 | — | — | CN | claimed |
| EP-0645438-A2 | Bleed resistance of dyes by counter-ion substitution | Hewlett-Packard Company (US) | 1995-03-29 | — | — | EP | claimed |
| CN-118873688-A | Chrysanthemum carbon quantum dot drug-loaded nanoparticle, chrysanthemum pollen drug depot and application thereof in soluble microneedle drug delivery system | 上海中医药大学 | 2024-11-01 | — | — | CN | disclosed |
| WO-2020224568-A1 | CDK INHIBITORS | QILU REGOR THERAPEUTICS INC. (CN) | 2020-11-12 | — | — | WO | disclosed |
| US-20060154256-A1 | Method for covalently attaching nucleosides and/or nucleotides on surfaces and method for determining coupling yields in the synthesis of nucleotides | CHEMOGENIX GMBH (DE) | 2006-07-13 | — | — | US | disclosed |
| US-20050143453-A1 | Selective preventing and therapeutic agents for progressive lesion after organic damage | ISHIBASHI MICHIO (JP) | 2005-06-30 | — | — | US | disclosed |
| US-6878745-B2 | Selective preventives/remedies for progressive lesions after organ damage | Ishibashi, Michio (JP) | 2005-04-12 | — | — | US | disclosed |
| EP-1438322-A2 | METHOD FOR COVALENTLY ATTACHING NUCLEOSIDES AND/OR NUCLEOTIDES ON SURFACES AND METHOD FOR DETERMINING COUPLING YIELDS IN THE SYNTHESIS OF NUCLEOTIDES | Chemogenix GmbH (DE) | 2004-07-21 | — | — | EP | disclosed |
| US-20030181506-A1 | Selective preventives/remedies for progressive lesions after organ damage | ISHIBASHI, MICHIO (JP) | 2003-09-25 | — | — | US | disclosed |
| WO-2003035664-A2 | METHOD FOR COVALENTLY ATTACHING NUCLEOSIDES AND/OR NUCLEOTIDES ON SURFACES AND METHOD FOR DETERMINING COUPLING YIELDS IN THE SYNTHESIS OF NUCLEOTIDES | CHEMOGENIX GMBH (DE) | 2003-05-01 | — | — | WO | disclosed |
| EP-1277747-A1 | SELECTIVE PREVENTIVES/REMEDIES FOR PROGRESSIVE LESIONS AFTER ORGAN DAMAGE | Ishibashi, Michio (JP) | 2003-01-22 | — | — | EP | disclosed |
| EP-0909156-A1 | USE OF HYDROGEL FORMERS AND AGENTS FOR THE TREATMENT OF KERATINOUS FIBRES | Hans Schwarzkopf & Henkel GmbH & Co. KG (DE) | 1999-04-21 | — | — | EP | disclosed |
| WO-1998000092-A1 | USE OF HYDROGEL FORMERS AND AGENTS FOR THE TREATMENT OF KERATINOUS FIBRES | HANS SCHWARZKOPF GMBH & CO. KG. (DE) | 1998-01-08 | — | — | WO | disclosed |
| EP-0645438-A2 | Bleed resistance of dyes by counter-ion substitution | Hewlett-Packard Company (US) | 1995-03-29 | — | — | EP | disclosed |
| US-3962209-A | PROCESS FOR PREPARING AZO DYESTUFFS WITH ORTHO-AZO CYANO GROUPS BY CYANO EXCHANGE OF METAL CYANIDES AND HALO DYESTUFFS | BAYER AKTIENGESELLSCHAFT (DT) | 1976-06-08 | — | — | US | disclosed |